The recent revelation that international inspectors failed to rid Syria of its chemical weapons arsenal, due to interference from the regime and incomplete knowledge of the full extent of the country’s stockpiles, has raised concerns about how effective the recently concluded nuclear deal with Iran can be. Ely Karmon, a senior research scholar...
Continue Reading >>Major Israeli Solar Field Connected to...
Israel connected the Ketura Solar field to its national powerCongressional Testimony: Anti-Boycott Laws Needed to...
The ultimate goal of the Boycott, Divestment and Sanctions (BDS)New Poll: Opposition to Iran Deal...
A poll conducted by Olive Tree Strategies and released todayTwo Policemen Killed in Bahrain Terror...
A bomb attack Tuesday in the northeastern city of Sitra, Bahrain killed two

by TheTower.org Staff |

by TheTower.org Staff |
American Jews disapprove of the nuclear deal with Iran, and overwhelmingly reject the deal when presented with more information on it, a new poll has found. The poll, which is the most extensive survey of American Jews and their views on the Iran nuclear deal to date, showed that 47 percent of...
Continue Reading >>
by TheTower.org Staff |
Top Democrats must lead the fight against the recently concluded nuclear deal with Iran, if for no other reason than to prevent the demise of their party, Martin Peretz, the longtime editor-in-chief of The New Republic and a board member of The Israel Project, wrote in The Democratic Party, on the Edge of the Abyss, published in...
Continue Reading >>
by TheTower.org Staff |
Three Jews who disappeared after seeking to escape from Iran via Pakistan in 1997 were captured and murdered, Israel’s intelligence agency the Mossad concluded based on newly acquired information, The Jerusalem Post reported yesterday. The three, Nourollah Rabizadeh and brothers Cyrus and Avraham Ghahremani, fled Tehran in February 1997. They...
Continue Reading >>
by TheTower.org Staff |
Israeli pharmaceutical giant Teva has agreed to purchase the global generics unit of the Ireland-based corporation Allergan PLC for $40.5 billion, the largest such acquisition in Israel’s history, The Times of Israel reported yesterday. Teva will pay $33.75 billion in cash and offer $6.75 billion of its stock to Allergan,...
Continue Reading >>
by TheTower.org Staff |
Forty years ago, the American Jewish community found itself faced with a White House that was determined to come to an arms control deal with a tyranny. Despite hesitation about challenging the Nixon administration’s policy of detente with the Soviet Union, the community and a group of senators pushed for...
Continue Reading >>




